4.8 Article

A genetic cell context-dependent role for ZEB1 in lung cancer

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

LAMC2 enhances the metastatic potential of lung adenocarcinoma

Y. W. Moon et al.

CELL DEATH AND DIFFERENTIATION (2015)

Article Medicine, Research & Experimental

Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy

Daniel L. Abravanel et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Multidisciplinary Sciences

Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers

Jin Sung Jang et al.

SCIENTIFIC REPORTS (2015)

Article Oncology

From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling

Panagiotis Ntziachristos et al.

CANCER CELL (2014)

Article Medicine, Research & Experimental

ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism

Yanan Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Oncology

Acquired resistance to TKIs in solid tumours: learning from lung cancer

D. Ross Camidge et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Review Pharmacology & Pharmacy

The ErbB/HER family of protein-tyrosine kinases and cancer

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2014)

Article Multidisciplinary Sciences

Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis

Yongqing Liu et al.

NATURE COMMUNICATIONS (2014)

Article Respiratory System

Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas

Alexis B. Cortot et al.

EUROPEAN RESPIRATORY REVIEW (2014)

Review Oncology

KRAS Mutation: Should We Test for It, and Does It Matter?

Patrick J. Roberts et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Review Biochemistry & Molecular Biology

The epigenetics of epithelial-mesenchymal plasticity in cancer

Wai Leong Tam et al.

NATURE MEDICINE (2013)

Article Medicine, Research & Experimental

ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression

Young-Ho Ahn et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Multidisciplinary Sciences

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

Kadoaki Ohashi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Biochemistry & Molecular Biology

Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells

Diana M. Vallejo et al.

EMBO JOURNAL (2011)

Article Biochemistry & Molecular Biology

The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells

Simone Brabletz et al.

EMBO JOURNAL (2011)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Review Biochemistry & Molecular Biology

The role of the ZEB family of transcription factors in development and disease

C. Vandewalle et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2009)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Multidisciplinary Sciences

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

Jeffrey A. Engelman et al.

SCIENCE (2007)

Article Medicine, General & Internal

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

W Pao et al.

PLOS MEDICINE (2005)

Article Biochemistry & Molecular Biology

Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation

SJ Cho et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Review Cell Biology

Untangling the ErbB signalling network

Y Yarden et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)